Name
Helve Kansi OÜ
Registry code
11316835
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
16.11.2006 (17)
Financial year
01.01-31.12
Capital
40 000.00 €
Activity
86211 - Provision of general medical treatment
757 694 €
185 841 €
25%
-
406 445 €
6
Submitted
No tax arrears
46%
36%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Helve Kansi 27.09.1965 (59) | 100% - 40 000.00 EEK | Board member | Direct ownership | Founder |
| 2019 19.06.2020 | 2020 25.06.2021 | 2021 20.06.2022 | 2022 20.06.2023 | 2023 16.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 204 049 € | 227 563 € | 245 902 € | 455 080 € | 757 694 € |
| Net profit (loss) for the period | 26 943 € | 49 414 € | 32 587 € | 41 818 € | 185 841 € |
| Profit Margin | 13% | 22% | 13% | 9% | 25% |
| Current Assets | 118 105 € | 175 070 € | 214 672 € | 168 398 € | 281 565 € |
| Fixed Assets | 47 222 € | 39 637 € | 29 995 € | 170 720 € | 234 795 € |
| Total Assets | 165 327 € | 214 707 € | 244 667 € | 339 118 € | 516 360 € |
| Current Liabilities | 31 042 € | 40 008 € | 46 881 € | 109 014 € | 109 915 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 134 285 € | 174 699 € | 197 786 € | 230 104 € | 406 445 € |
| Employees | 3 | 3 | 3 | 6 | 6 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 34 400.6 € | 36 339.14 € | 6 |
| 2023 Q4 | - | 36 336.01 € | 37 983.16 € | 10 |
| 2023 Q3 | - | 37 985.5 € | 40 129.28 € | 11 |
| 2023 Q2 | - | 28 126.85 € | 29 600.94 € | 9 |
| 2023 Q1 | - | 31 600.48 € | 32 809.83 € | 9 |
| 2022 Q4 | - | 29 266.46 € | 31 184.49 € | 9 |
| 2022 Q3 | - | 24 065.26 € | 25 328.72 € | 8 |
| 2022 Q2 | - | 23 615.56 € | 24 554.1 € | 3 |
| 2022 Q1 | - | 17 793.5 € | 18 382.04 € | 5 |
| 2021 Q4 | - | 18 923.93 € | 19 319.9 € | 4 |
| 2021 Q3 | - | 11 824.58 € | 12 235.97 € | 4 |
| 2021 Q2 | - | 14 108.2 € | 14 568.5 € | 3 |
| 2021 Q1 | - | 14 009.26 € | 14 150.37 € | 3 |
| 2020 Q4 | - | 15 560.17 € | 16 115.27 € | 4 |
| 2020 Q3 | - | 10 113.25 € | 10 464.57 € | 4 |
| 2020 Q2 | - | 10 015 € | 10 178.92 € | 3 |
| 2020 Q1 | - | 9 439.2 € | 9 921.04 € | 3 |
